Download the app and get the day’s most important stories.

October 9, 2019 | Via The Guardian

Zantac in Global Recall over ‘Unacceptable’ Levels of Potential Carcinogen

GlaxoSmithKline is recalling the popular heartburn medicine Zantac in all markets, days after the US Food and Drug Administration (FDA) found “unacceptable” levels of probable cancer-causing impurity in the drug. Zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year.

February 2020
M T W T F S S
« Jan    
 12
3456789
10111213141516
17181920212223
242526272829